In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Generic User Fees Must Be Considered Due To Ballooning ANDAs – FDA’s Galson

Executive Summary

The "exponential" growth of ANDA submissions necessitates an examination of user fees for generic applications, Center for Drug Evaluation & Research Director Steven Galson told the Generic Pharmaceutical Association's Fall Technical Conference Oct. 24

You may also be interested in...



FDA Faces Pricing Pressure As Generic Drug User Fee Debate Begins

Emerging discussions on the creation of a user fee program for generic drug review place FDA in the awkward position of potentially being seen as an arbiter of drug prices - at least indirectly

FDA Faces Pricing Pressure As Generic Drug User Fee Debate Begins

Emerging discussions on the creation of a user fee program for generic drug review place FDA in the awkward position of potentially being seen as an arbiter of drug prices - at least indirectly

Citizen Petition Reform Proposals Include User Fees, Payments For Lost Profits

User fees for citizen petitions may discourage abuse of the process, Sandoz VP-Intellectual Property & Regulatory Shashank Upadhye said Sept. 30 at the Institute for International Research's Annual Generic Drugs Summit in Washington, D.C

Related Content

Topics

UsernamePublicRestriction

Register

PS046489

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel